These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25168029)

  • 21. Protein Targets of Acetaminophen Covalent Binding in Rat and Mouse Liver Studied by LC-MS/MS.
    Geib T; Moghaddam G; Supinski A; Golizeh M; Sleno L
    Front Chem; 2021; 9():736788. PubMed ID: 34490218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid Chromatography-Tandem Mass Spectrometry Analysis of Acetaminophen Covalent Binding to Glutathione
    Geib T; Lento C; Wilson DJ; Sleno L
    Front Chem; 2019; 7():558. PubMed ID: 31457004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of glyceraldehyde-3-phosphate dehydrogenase by a reactive metabolite of acetaminophen and mass spectral characterization of an arylated active site peptide.
    Dietze EC; Schäfer A; Omichinski JG; Nelson SD
    Chem Res Toxicol; 1997 Oct; 10(10):1097-103. PubMed ID: 9348431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acetyl-p-benzoquinone imine, the toxic metabolite of acetaminophen, is a topoisomerase II poison.
    Bender RP; Lindsey RH; Burden DA; Osheroff N
    Biochemistry; 2004 Mar; 43(12):3731-9. PubMed ID: 15035644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of caffeine and theophylline on acetaminophen pharmacokinetics: P450 inhibition and activation.
    Lee CA; Lillibridge JH; Nelson SD; Slattery JT
    J Pharmacol Exp Ther; 1996 Apr; 277(1):287-91. PubMed ID: 8613932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetaminophen binds to mouse hepatic and renal DNA at human therapeutic doses.
    Rogers LK; Moorthy B; Smith CV
    Chem Res Toxicol; 1997 Apr; 10(4):470-6. PubMed ID: 9114986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen.
    Dahlin DC; Miwa GT; Lu AY; Nelson SD
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1327-31. PubMed ID: 6424115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The covalent binding of acetaminophen to protein. Evidence for cysteine residues as major sites of arylation in vitro.
    Streeter AJ; Dahlin DC; Nelson SD; Baillie TA
    Chem Biol Interact; 1984 Mar; 48(3):349-66. PubMed ID: 6713598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A reliable method of liquid chromatography for the quantification of acetaminophen and identification of its toxic metabolite N-acetyl-p-benzoquinoneimine for application in pediatric studies.
    Flores-Pérez C; Chávez-Pacheco JL; Ramírez-Mendiola B; Alemón-Medina R; García-Álvarez R; Juárez-Olguín H; Flores-Pérez J
    Biomed Chromatogr; 2011 Jul; 25(7):760-6. PubMed ID: 20878659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-acetyl-p-benzoquinone imine-induced protein thiol modification in isolated rat hepatocytes.
    Weis M; Morgenstern R; Cotgreave IA; Nelson SD; Moldéus P
    Biochem Pharmacol; 1992 Apr; 43(7):1493-505. PubMed ID: 1567474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reaction between metabolically activated acetaminophen and phosphorothioate oligonucleotides.
    Copple BL; Gmeiner WM; Iversen PL
    Toxicol Appl Pharmacol; 1995 Jul; 133(1):53-63. PubMed ID: 7597710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The killing of cultured hepatocytes by N-acetyl-p-benzoquinone imine (NAPQI) as a model of the cytotoxicity of acetaminophen.
    Harman AW; Kyle ME; Serroni A; Farber JL
    Biochem Pharmacol; 1991 Apr; 41(8):1111-7. PubMed ID: 2009090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the degradation of electrochemically-generated reactive drug metabolites by quantitative NMR.
    Bussy U; Giraudeau P; Tea I; Boujtita M
    Talanta; 2013 Nov; 116():554-8. PubMed ID: 24148444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation of an electrochemical method for studying reactive phase-I metabolites: correlation to in vitro drug metabolism.
    Madsen KG; Olsen J; Skonberg C; Hansen SH; Jurva U
    Chem Res Toxicol; 2007 May; 20(5):821-31. PubMed ID: 17447796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A tandem MS precursor-ion scan approach to identify variable covalent modification of albumin Cys34: a new tool for studying vascular carbonylation.
    Aldini G; Regazzoni L; Orioli M; Rimoldi I; Facino RM; Carini M
    J Mass Spectrom; 2008 Nov; 43(11):1470-81. PubMed ID: 18457351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A quantum chemical study of the reactivity of acetaminophen (paracetamol) toxic metabolite N-acetyl-p-benzoquinone imine with deoxyguanosine and glutathione.
    Klopčič I; Poberžnik M; Mavri J; Dolenc MS
    Chem Biol Interact; 2015 Dec; 242():407-14. PubMed ID: 26551927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry.
    Kleinova M; Belgacem O; Pock K; Rizzi A; Buchacher A; Allmaier G
    Rapid Commun Mass Spectrom; 2005; 19(20):2965-73. PubMed ID: 16178042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women.
    Mian P; van den Anker JN; van Calsteren K; Annaert P; Tibboel D; Pfister M; Allegaert K; Dallmann A
    Clin Pharmacokinet; 2020 Jan; 59(1):97-110. PubMed ID: 31347013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis.
    Berna MJ; Zhen Y; Watson DE; Hale JE; Ackermann BL
    Anal Chem; 2007 Jun; 79(11):4199-205. PubMed ID: 17447729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of acetaminophen-reactive metabolite formation by methylxanthines and known cytochrome P-450 activators.
    Lee CA; Thummel KE; Kalhorn TF; Nelson SD; Slattery JT
    Drug Metab Dispos; 1991; 19(5):966-71. PubMed ID: 1686244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.